Monthly Archives: July 2019

Seacoast Commerce Bank Announces Hiring of Ian Dooley, SVP and SBA Business Development Officer, San Antonio, TX

SAN DIEGO, CA / ACCESSWIRE / July 29, 2019 / Seacoast Commerce Bank, a wholly-owned subsidiary of Seacoast Commerce Banc Holdings (OTC PINK: SCBH) today announced the hiring of Ian Dooley as Senior Vice President and Small Business Administration (“SBA”) Business Development Officer. Mr. Dooley will be located in San Antonio, Texas. He brings proven success in SBA production to Seacoast’s already “best in class” SBA Division and will be helping small businesses facilitate the acquisition, development, and refinance of their commercial real estate properties.

Ian has over 20 years of extensive banking and finance experience spanning servicing, credit analysis, underwriting, management and business development. While attending the University of Texas at San Antonio (“UTSA”), Ian began his career with Citibank in 1998 then moved to USAA’s Mortgage Lending Division in 2002 where he rapidly became a top 5 lender, serving clients throughout Texas. After earning his graduate degree from UTSA in 2012, he became an analyst for Wells Fargo where he worked closely with market lenders and their borrowers to ensure accurate, and complete underwriting packages to facilitate quick turn-times. Most recently, Ian worked at TransPecos Bank in San Antonio, Texas, where he was promoted to be their SBA Department Manager and asked to build their SBA business from scratch. As a player/coach, Ian originated $65 million of SBA loans over the last four years.

“We are very excited that Ian has decided to join our team. His deep SBA experience and expertise helping small business entrepreneurs pursue their dreams of owning or improving their facilities will serve us well as we look to expand our business in the San Antonio and Austin markets,” stated Don Mercer, Executive Vice President, SBA National Sales Manager. Ian can be reached by email at idooley@sccombank.com or at (210) 584-6785.

About Seacoast Commerce Banc Holdings: Seacoast Commerce Banc Holdings is a bank holding company with one wholly-owned banking subsidiary, Seacoast Commerce Bank. Both the holding company and the bank are headquartered in San Diego, California, with the Bank having four full-service banking branches in San Diego and Orange County, California, and loan and deposit production offices throughout Arizona, California, Colorado, Georgia, Illinois, Oregon, Massachusetts, Nevada, Texas, Utah, Virginia and Washington.

For more information on Seacoast Commerce Banc Holdings, please visit www.scbholdings.com; to learn more about Seacoast Commerce Bank, visit www.sccombank.com, or contact Richard M. Sanborn, President and Chief Executive Officer at (858) 432-7001.

For more information on Seacoast Commerce Bank’s SBA lending platform, please contact David H. Bartram, Senior Executive Vice President, Chief Operating Officer, and SBA Division Manager at (858) 432-7002.

Certain statements in this press release, including statements regarding the anticipated development and expansion of the Bank’s business, and the intent, belief or current expectations of the Bank, its directors or its officers, are “forward-looking” statements (as such term is defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such “forward-looking” statements. These risks and uncertainties include, but are not limited to, risks related to the local and national economy, the Bank’s performance and regulatory matters.

SOURCE: Seacoast Commerce Bank

ReleaseID: 553799

Atlas Mara Limited Announces Buyback of Shares – 29/07/2019

Atlas Mara Repurchase of Shares and Total Voting Rights Update

TORTOLA / ACCESSWIRE / July 29, 2019 / Atlas Mara Limited (“Atlas Mara” or the “Company” and, including its subsidiaries, the “Group”), the sub-Sahara African financial services group, today announces that on 26 July 2019, the Company repurchased 4,426 shares, all of which were purchased at an average price of $1.30 and will be held as treasury shares.

Atlas Mara repurchased shares pursuant to the authority granted by its Board of Directors, announced in its Q3 2018 Results RNS, to reinstate a lapsed share purchase program. The granted authority is for Atlas Mara to repurchase the Company’s issued share capital up to an aggregate market value equivalent to $10 million by way of its nominated brokers.

As a result of the repurchase of shares, Atlas Mara’s total number of ordinary shares in issue is 174,618,767 of which 1,471,819 are now held in treasury with an additional 3,298,298 ordinary shares held in escrow as part of the contingent consideration for the acquisition of FBZ. Atlas Mara hereby notifies the market that the total number of voting rights in Atlas Mara is 169,848,650. In accordance with rule 5.6.1 of the Financial Conduct Authority’s Disclosure and Transparency Rules (“DTRs”), this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Atlas Mara under the DTRs.

Contact Details
Investors
Kojo Dufu, +1 212 883 4330

Media
Anthony Silverman, +44 (0)7818 036 579

About Atlas Mara
Atlas Mara Limited (LON: ATMA) is a financial services institution founded by Bob Diamond and listed on the London Stock Exchange. With a presence in seven sub-Saharan countries, Atlas Mara aims to be a positive disruptive force in the markets in which we operate by leveraging technology to provide innovative and differentiated product offerings, deliver excellent customer service and accelerate financial inclusion. For more information, visit www.atlasmara.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: Atlas Mara

ReleaseID: 553798

Bitsdaq announces the Semi-Anniversary Carnival and BQQQ listing on BCEX Global

SINGAPORE / ACCESSWIRE / July 29, 2019 / To celebrate the semi-anniversary, Bitsdaq will hold the Bitsdaq Semi-anniversary Carnival from July 29, with several events to give back to new and existing supporters. The details will be announced on the official website. At the same time, BQQQ will be listed on BCEX Global exchange on July 30.

Bitsdaq Semi-anniversary Carnival consists of BQQQ airdrops, slogan, articles, short video rewarded campaign and lucky draws, free Bitsdaq giveaways for new registrations, etc. Everyone can participate in the events and get rewarded.

Ricky Ng, founder and CEO of Bitsdaq, added that since its launch, Bitsdaq has become a dark horse among the exchanges thanks to the support of the loyal community and that Bitsdaq will always put the interests of its supporters first:

He says, “Since the official launch on January 29, 2019, Bitsdaq has delivered impressive results to the vast number of users, thanks to the exchange partnership and technical support from Bittrex. Bitsdaq has been learning and experimenting with both user growth and collaboration with projects and ecosystem partners. All these are not possible without the supporters, and we will continue to launch a variety of events to give back to them.”

Bitsdaq has stellar records since the official launch.

Product developments have always placed user experience and innovation first; Launch of Bitsdaq Launchpad for quality projects and successfully completed the IEO of the platform token – BQQQ; Launched the Android and iOS App on Google Play and App Store which has received over 10,000 top tier reviews. To date, Bitsdaq has accumulated more than 2 million registered users and more than 150,000 global followers in global communities. Recently, Bitsdaq has listed more than 10 high-quality projects. Bitsdaq Fantastar Program was also launched to better support quality projects where Bitsdaq will provide comprehensive marketing and strategic support to the projects team.

BQQQ’s successful IEO marks another step forward for Bitsdaq ecosystem. BQQQ has received strategic investments from NEO Global Capital (NGC) and Consensus FinTech Group. At the same time, BQQQ recently caught the attention of investors with more application scenario, such as the official listing on BQCoinPlanet App, the launch of BQQQ/ETH trading pair, and the upcoming launch on BCEX Global exchange on July 30.

With the continued growth of the user base and the diversification of investment needs, Bitsdaq team is planning to perform a major upgrade to the exchange, while tapping into new market potential. At the same time, Bitsdaq will also accelerate collaboration with partners to foster high-quality projects and explore projects with good potential. Bitsdaq believes in protecting the interests of users, the importance of value investing, and being responsible to investors.

Scan the QR code below to download the latest version of the Bitsdaq APP!

Bitsdaq Social Media Page:

Twitter English: https://twitter.com/BitsdaqExchange

Twitter Chinese: https://twitter.com/BitsdaqChinese

Youtube: https://www.youtube.com/channel/UCR5E7EH5zvd6gXK0f4NWANQ

Bitsdaq Community:

Bitsdaq Telegram English: https://t.me/BitsdaqExchangeOfficial

Bitsdaq Telegram Chinese: https://t.me/BitsdaqExchangeChinese

Bitsdaq Telegram Turkish: https://t.me/BitsdaqofficialTurkish

Bitsdaq Telegram Russian: https://t.me/BitsdaqOfficialRussia

Bitsdaq Telegram Vietnamese: https://t.me/BitsdaqOfficialVietnam

Bitsdaq Telegram India: https://t.me/BitsdaqOfficialIndia

Bitsdaq Official Channel: https://t.me/BitsdaqOfficialChannel

About Bitsdaq
www.bitsdaq.com

marketing@bitsdaq.com

Bitsdaq is a secure, reliable and advanced digital assets trading platform operating in Asia and built on cutting edge trading technology. The company provides opportunities and solutions for customers who want access to a broader selection of digital assets on a secure and reliable platform.

SOURCE: Bitsdaq

ReleaseID: 553796

Bariatric Surgery Devices Market 2018| Business Scope for Forecast period 2024

A report released by Global Market Insights, the Bariatric Surgery Devices Market size to exceed $ 2.2 bn by 2024, with significant growth forecast for the North American, European and APAC markets.

Selbyville, United States – July 29, 2019 /MarketersMedia/

Bariatric Surgery Devices Market size is set to exceed USD 2.2 billion by 2024; according to a new research report by Global Market Insights. High demand for minimally invasive surgical procedures will significantly drive bariatric surgery devices market growth over the forecast period. Reduction in post-operative trauma and complications with use of minimally invasive surgical procedure is the major growth driver. Reduced hospital stays, and lesser healing time are other advantages of bariatric surgical devices. Such factors will favor considerable growth in the future.

Increasing government funding will spur demand for bariatric surgeries in upcoming years. For instance, National Institute of Diabetes and Digestive Kidney Diseases (NIDDK) provided about USD 1.3 million to Miriam Hospital in US for development of advanced technologies that support bariatric surgery. This will positively impact adoption of bariatric surgical procedures, thereby driving business growth during the forecast period.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2735

Minimally invasive surgical device segment accounted for largest revenue of USD 1,378.1 million in 2017. Patients with gastrointestinal diseases using minimally invasive techniques experience less pain, reduced costs of treatment, and recovery time. Improved design to provide maximum efficiency will favor segmental growth in the future.
Sleeve gastrectomy segment is expected to grow at 6.1% during the forecast timeframe. Segmental growth is attributable to lesser number of complications and higher efficacy. According to American Society for Metabolic and Bariatric Surgery (ASMBS), about 59% of bariatric surgeries performed were sleeve gastrectomy. Increasing patient preference and affordability of sleeve gastrectomy will favor segmental growth over forecast timeframe.

U.S. bariatric surgery devices market will grow at 5.6%, owing to high pervasiveness of obesity. According to National Institute of Diabetes and Digestive Kidney Diseases (NIDDK), 1 in 3 adults in U.S. suffer from obesity. High prevalence of obesity coupled with high disposable income and increasing government expenditure on healthcare will further lead to business growth in the future.

Japan bariatric surgery devices market accounted for revenue size of USD 92.6 million in 2017 owing to rising number of bariatric surgical procedures including sleeve gastrectomy. According to NCBI 2015 report, more than 70% sleeve gastrectomy surgical procedures were performed in Japan. In addition, sedentary lifestyle as well as unhealthy diet habits are also contributing factors for obesity that will foster industry growth in upcoming years.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2735

Report Content

Chapter 1. Methodology
1.1. Methodology
1.2. Market definitions
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Bariatric surgery devices market industry 3600 synopsis, 2013 – 2024
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Procedure trends
2.1.4. Regional trends
Chapter 3. Bariatric Surgery Devices Market Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 – 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Increasing demand for minimally invasive surgical procedures worldwide
3.3.1.2. Rising incidences of obesity in Asia Pacific
3.3.1.3. Technological advancements in developed economies
3.3.1.4. Increasing government funding for bariatric surgery in developed countries
3.3.2. Industry pitfalls & challenges
3.3.2.1. High cost associated with surgical devices
3.3.2.2. Stringent regulatory scenario in developed countries
3.3.2.3. Dearth of skilled healthcare professionals in developing economies
3.4. Growth potential analysis
3.4.1. By product
3.4.2. By procedure
3.5. Regulatory scenario
3.6. Porter’s analysis
3.7. Competitive landscape, 2017
3.7.1. Strategy dashboard
3.8. PESTEL analysis

Browse Report Summary @ https://www.gminsights.com/industry-analysis/bariatric-surgery-devices-market

Some of the prominent players involved in bariatric surgery devices market are Apollo Endosurgery, B. Braun Melsungen AG, CONMED Corporation, Ethicon Inc. (Johnson & Johnson), Integra Life Sciences Holding Corporation, Intuitive Surgical, Medtronic, Olympus Corporation, Reshape Lifesciences, and W. L. Gore & Associates, Inc. These firms adopt strategic initiatives including mergers and acquisitions, new product launch and geographical expansion. For instance, in January 2017, Ethicon acquired Megadyne Medical Products, Inc., a medical device company that develops, manufactures electrosurgical tools. This acquisition will help in broadening its product portfolio as well as business revenue.

Related Report @ https://www.gminsights.com/industry-analysis/ventricular-assist-devices-market

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone:1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: www.gminsights.com/

Contact Info:
Name: Arun Hegde
Email: Send Email
Organization: Global market insights
Phone: 1-888-689-0688
Website: https://www.gminsights.com/pressrelease/bariatric-surgery-devices-market

Source URL: https://marketersmedia.com/bariatric-surgery-devices-market-2018-business-scope-for-forecast-period-2024/88902160

Source: MarketersMedia

Release ID: 88902160

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of STG, RMED and INS

NEW YORK, NY / ACCESSWIRE / July 29, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Sunlands Technology Group (NYSE: STG)
Class Period: shareholders of Sunlands Technology Group who purchased shares pursuant and/or traceable to Sunlands’ March 2018 initial public stock offering.
Lead Plaintiff Deadline: August 26, 2019

Throughout the class period, Sunlands Technology Group allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Sunlands’ student enrollment was declining; (2) Sunlands’ gross billings were declining; (3) Sunlands’ marketing tactics were not as robust as described in the Registration Statement; and (4) as a result, Defendants’ statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Learn about your recoverable losses in STG: http://www.kleinstocklaw.com/pslra-1/sunlands-technology-group-loss-submission-form?id=2645&from=1

Ra Medical Systems, Inc. (NYSE: RMED)
Class Period: stockholders that purchased Ra Medical securities pursuant and/or traceable to the Company’s September 2018 initial public offering.
Lead Plaintiff Deadline: August 6, 2019

Ra Medical Systems, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the Company’s evaluation of sales personnel candidates was inadequate; (2) the Company’s training program for sales personnel was inadequate; (3) as a result, the Company could not reasonably assure that its newly hired sales personnel were adequately experienced; (4) as a result, the Company would suffer a shortage of qualified sales personnel; (5) the Company’s manufacturing process could not reasonably support increased catheter production; (6) as a result, the Company would suffer production delays; and (7) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in RMED: http://www.kleinstocklaw.com/pslra-1/ra-medical-systems-inc-loss-submission-form?id=2645&from=1

Intelligent Systems Corporation (NYSE: INS)
Class Period: January 23, 2019 to May 29, 2019
Lead Plaintiff Deadline: September 9, 2019

Throughout the class period, Intelligent Systems Corporation allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) Defendant Petit, the “financial expert” on the Company’s Audit Committee, engaged in accounting fraud as the CEO of MiMedx Group; (2) the Company’s CEO, Defendant Strange, engaged in undisclosed related-party transactions with Defendant Petit and others and had an undisclosed personal relationship with the Company’s auditor; (3) the Company had its employees set up or take control of shell companies in Asia so they could partake in undisclosed related-party transactions for the purpose of either fabricating revenue for the Company and/or siphoning money out of the Company; and (4) as a result, Defendants’ statements about Intelligent Systems’ business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.

Learn about your recoverable losses in INS: http://www.kleinstocklaw.com/pslra-1/intelligent-systems-corporation-loss-submission-form?id=2645&from=1

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm

ReleaseID: 553797

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Eagle Bancorp, Inc.

WILMINGTON, DE / ACCESSWIRE / July 29, 2019 / Rigrodsky & Long, P.A.:

Do you, or did you, own shares of Eagle Bancorp, Inc. (NASDAQ CM: EGBN)?

Did you purchase your shares between March 2, 2015 and July 17, 2019, inclusive?

Did you lose money in your investment?

Rigrodsky & Long, P.A. announces that a complaint has been filed in the United States District Court for the Southern District of New York on behalf of all persons or entities that purchased the common stock of Eagle Bancorp, Inc. (“Eagle Bancorp” or the “Company”) (NASDAQ CM: EGBN) between March 2, 2015 and July 17, 2019, inclusive (the “Class Period”), alleging violations of the Securities Exchange Act of 1934 against the Company and certain of its officers (the “Complaint”).

If you purchased shares of Eagle Bancorp during the Class Period, or purchased shares prior to the Class Period and still hold Eagle Bancorp, and wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact Seth D. Rigrodsky or Timothy J. MacFall at Rigrodsky & Long, P.A., 300 Delaware Avenue, Suite 1220, Wilmington, DE 19801, by telephone at (888) 969-4242, by e-mail at info@rl-legal.com, or at http://rigrodskylong.com/contact-us/.

The Complaint alleges that throughout the Class Period, defendants made materially false and misleading statements, and omitted materially adverse facts, about the Company’s business, operations and prospects. Specifically, the Complaint alleges that the defendants concealed from the investing public that: (i) Eagle Bancorp’s internal controls and procedures and compliance policies were inadequate; (ii) the foregoing shortcoming created a foreseeable risk of heightened regulatory scrutiny and the need for the Company undertake its own internal investigations; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times. As a result of defendants’ alleged false and misleading statements, the Company’s stock traded at artificially inflated prices during the Class Period.

According to the Complaint, on July 17, 2019, Eagle Bancorp disclosed rising legal costs stemming from ongoing internal and government investigations of “the Company’s identification, classification and disclosure of related party transactions; the retirement of certain former officers and directors; and the relationship of the Company and certain of its former officers and directors with a local public official.”

On this news, shares of Eagle Bancorp declined over 26%, closing at $39.10 per share on July 18, 2019, on heavy trading volume.

If you wish to serve as lead plaintiff, you must move the Court no later than September 23, 2019. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any member of the proposed class may move the court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.

Rigrodsky & Long, P.A., with offices in Delaware, New York, and California, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in numerous cases nationwide, including federal securities fraud actions, shareholder class actions, and shareholder derivative actions.

Attorney advertising. Prior results do not guarantee a similar outcome.

CONTACT:
Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Timothy J. MacFall
(888) 969-4242
(516) 683-3516
Fax: (302) 654-7530
info@rl-legal.com
http://www.rigrodskylong.com

SOURCE: Rigrodsky & Long P.A.

ReleaseID: 553791

SHAREHOLDER ALERT – Mammoth Energy Services, Inc. (TUSK) – Bronstein, Gewirtz & Grossman, LLC Announces Class Action and Lead Plaintiff Deadline: August 6, 2019

NEW YORK, NY / ACCESSWIRE / July 29, 2019 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Mammoth Energy Services, Inc.(“Mammoth” or the “Company”) (NASDAQ: TUSK) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Mammoth securities from October 19, 2017 through June 5, 2019, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/tusk.

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Mammoth’s subsidiary, Cobra, improperly obtained two infrastructure contracts with PREPA that totaled over $1.8 billion; (2) specifically, the contracts were awarded as the result of improper steering and not a competitive RFP process; and (3) as a result, Defendants’ statements about Mammoth’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

On May 24, 2019, the Wall Street Journal published an article entitled “FEMA Official Probed Over Puerto Rico Power Restoration”. According to the article, a high-ranking Federal Emergency Management Agency official who oversaw the reconstruction of Puerto Rico’s electrical grid after Hurricane Maria is under investigation for allegedly steering work to one of Mammoth’s subsidiaries. The subsidiary had signed separate contracts worth up to $900 million and $945 million to repair downed transmission and distribution lines in Puerto Rico. Following publication of the article, Mammoth’s stock price fell $0.50 per share, or roughly 4%, to close at $11.74 per share on May 24, 2019. Then, on June 5, 2019, the Wall Street Journal published a second article, entitled “Puerto Rico Grid Contractor Caught Up in Federal Probes”. The article reported that the Federal Bureau of Investigation has launched a criminal inquiry into Mammoth’s power restoration work in Puerto Rico, and that the Department of Homeland Security’s Inspector General is probing the Company’s “rates for linemen, equipment and security under $1.85B in contracts with the Puerto Rico Electric Power Authority.” On this news, Mammoth’s stock price fell $1.67 per share, or 14.91%, to close at $9.53 per share on June 5, 2019.

If you wish to review a copy of the Complaint you can visit the firm’s site: www.bgandg.com/tusk or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss in Mammoth you have until August 6, 2019 to request that the Court appoint you as lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz

212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 553717

Just Energy Group Inc. (JE) Investigation – Bronstein, Gewirtz & Grossman, LLC

NEW YORK, NY / ACCESSWIRE / July 29, 2019 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Just Energy Group Inc. (“Just Energy” or “the Company”) (NYSE:JE). Investors who purchased Just Energystockare encouraged to obtain additional information and assist the investigation by visiting the firm’s site: www.bgandg.com/je.

The investigation concerns whetherJust Energyand certain of its officers and/or directors have violated federal securities laws.

On July 23, 2019, Just Energy disclosed that it had “identified customer enrollment and non-payment issues, primarily in Texas, over the past 12 months” and consequently expected an impairment charge of CAD $45 to $50 million to its Texas residential accounts receivable. On this news, Just Energy’s stock price fell $0.66 per share, or 15.07%, to close at $3.72 per share on July 23, 2019.

If you are aware of any facts relating to this investigation, or purchased Just Energyshares,you can assist this investigation by visiting the firm’s site: www.bgandg.com/je. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz and Grossman, LLC

ReleaseID: 553794

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In CannTrust Holdings Inc. To Contact The Firm

NEW YORK, NY / ACCESSWIRE / July 29, 2019 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in CannTrust Holdings Inc. (“CannTrust” or the “Company”) (NYSE: CTST) of the September 9, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

If you invested in CannTrust stock or options between November 14, 2018 and July 5, 2019 and would like to discuss your legal rights, click here: www.faruqilaw.com/CTST. There is no cost or obligation to you.

You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.

CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017

Attn: Richard Gonnello, Esq.

rgonnello@faruqilaw.com

Telephone: (877) 247-4292 or (212) 983-9330

The lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of all those who purchased CannTrust common stock between November 14, 2018 and July 5, 2019 (the “Class Period”). The case, Alvarado v. CannTrust Holdings Inc. et al., No. 19-cv-06438 was filed on July 11, 2019.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: 1) while the Company represented that its facilities were licensed, between October 2018 and March 2019 the Company had grown cannabis in five unlicensed rooms in violation of Canadian law causing the Company’s Niagara Perpetual Harvest Facility in Pelham, Ontario to be non-compliant with certain Canadian regulations; 2) that the Company had shipped unlicensed cannabis from the Company’s Niagara Perpetual Harvest Facility to at least StenoCare in Denmark in violation of the Canadian Cannabis Act; 3) that Company employees provided materially inaccurate information to Canadian regulators; and 4) that due to these undisclosed material negative conditions, the Company’s was facing undisclosed, material risks, including inventory holds of a material amount of the Company’s product, product shortages as a result of inventory holds, increased regulatory scrutiny, material delays to further licensing, and the material loss of customers

On July 8, 2019, CannTrust announced that its greenhouse facility in Pelham, Ontario, was audited by Health Canada and found to be “non-compliant.” Health Canada has placed a hold on approximately 5,200 kilograms of dried cannabis that was harvested in unlicensed rooms at the Pelham facility, until it deems CannTrust is compliant with regulations. CannTrust also said that it instituted a voluntary hold on approximately 7,500 kilograms of dried cannabis equivalent that also was produced in the unlicensed rooms.

On this news, the Company’s stock price fell from $4.94 per share on July 5, 2019 to $3.83 per share on July 8, 2019-a $1.11 or 22.47% drop.

Similarly, on July 9, 2019, MarketWatch reported that BMO Capital Markets downgraded CannTrust stock, the Financial Post reported that the Company’s Chief Executive Officer, Defendant Peter Aceto (“Aceto”) confirmed that some of the cannabis grown by Canntrust Holdings in unlicensed rooms at its Niagara facility has already been shipped to provinces across Canada, and MarketWatch reported that StenoCare, the Company’s Denmark-based joint venture partner, said it had received a number of batches of cannabis from CannTrust and after investigating, found that one was from part of the unlicensed CannTrust grow.

On this news, the Company’s stock price fell from $3.83 per share on July 8, 2019 to $3.60 per share on July 9, 2019-a $0.23 or 6.01% drop.

The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.

Faruqi & Faruqi, LLP also encourages anyone with information regarding CannTrust’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

SOURCE: Faruqi & Faruqi, LLP

ReleaseID: 553793

Class Action Reminder – FedEx Corporation (FDX), Acer Therapeutics Inc. (ACER) & Diebold Nixdorf, Incorporated (DBD) – Bronstein, Gewirtz & Grossman, LLC

NEW YORK, NY / ACCESSWIRE / July 29, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

FedEx Corporation (NYSE: FDX)
Class Period: September 19, 2017 – December 18, 2018
Deadline: August 26, 2019
For more info: www.bgandg.com/fdx

The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (i) TNT’s overall package volume growth was slowing as TNT’s large customers permanently took their business to competitors after the Cyberattack; (ii) as a result of the customer attrition, TNT was experiencing an increased shift in product mix from higher-margin parcel services to lower-margin freight services; (iii) the anticipated costs and timeframe to integrate and restore the TNT network were significantly larger and longer than disclosed; (iv) FedEx was not on track to achieve the TNT Income Improvement Target; and (v) as a result of these undisclosed negative trends and cost issues, FedEx’s positive statements about TNT’s recovery from the Cyberattack, integration into FedEx’s legacy operations, customer mix, customer service levels, profitability, and prospects lacked a reasonable basis.

Acer Therapeutics Inc. (NASDAQ: ACER)
Class Period: September 25, 2017 – June 24, 2019
Deadline: August 30, 2019
For more info: www.bgandg.com/acer

The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Acer lacked sufficient data to support filing EDSIVO’s NDA with the FDA for the treatment of vEDS; (2) the Ong Trial was an inadequate and ill-controlled clinical study by FDA standards, and was comprised of an insufficiently small group size to support EDSIVO’s NDA; (3) consequently, the FDA would likely reject EDSIVO’s NDA; and (4) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Diebold Nixdorf, Incorporated (NYSE: DBD)
Class Period: May 4, 2017 – July 4, 2017
Deadline: September 3, 2019
For more info: www.bgandg.com/dbd

The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company was experiencing delays in systems rollouts as well as a longer customer decision-making process and order-to-revenue conversion cycle; (2) the foregoing issues were negatively impacting the Company’s services business and operations; and (3) as a result, the Company’s public statements were materially false and misleading at all relevant times.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz

212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 553735